Disease-A-Month
Volume 54, Issue 12 , Pages 801-806 , December 2008

Prevention and Control of Methicillin-Resistant Staphylococcus aureus

References 

  1. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide program to improve compliance with hand hygiene. Lancet. 2000;356:1307–1312
  2. Siegel E, Jackson M, Chiarello L, et al. Management of multidrug-resistant organisms in healthcare settings, 2006 (Centers for Disease Control). http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdfAccessed May 15, 2008
  3. Mertz D, Frei R, Jaussi B, et al. Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus.. Clin Infect Dis. 2007;45:475–477
  4. Eveillard M, Lassence A, Lancien E, et al. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistance Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol. 2006;27:181–184
  5. Shitrit P, Gottesman BS, Katzir M, et al. Active surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreases the incidence of MRSA bacteremia. Infect Control Hosp Epidemiol. 2006;27:1004–1008
  6. McGinigle K, Gourlay M, Buchanan I. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and coasts: a systematic review. Clin Infect Dis. 2008;46:1717–1725
  7. Robicsek A, Beaumont J, Paule S, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148:409–418
  8. Habarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. J Am Med Assoc. 2008;299:1149–1157
  9. Weber S, Huang S, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the joint SHEA and APIC task force. Infect Control Hosp Epidemiol. 2007;28:249–260
  10. Bhalla A, Pultz N, Gries D, et al. Acquisition of nosocomial pathogens on hands alter contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol. 2004;25:164–167
  11. Boyce J, Potter-Bynoe G, Chenevert C, et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol. 1997;18:622–627
  12. Blythe D, Keenlyside D, Dawson SJ, et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect. 1998;38:67–69
  13. Wang L, Barret JF. Control and prevention of MRSA infections. Methods Mol Bio. 2007;391:209–225
  14. Daum RS. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.. N Engl J Med. 2007;357:280–290
  15. Huang SS, Diekema DJ, Warren D, et al. Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis. 2008;46:1241–1247
  16. Jones TF, Creech CB, Erwin P, et al. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006;42:e76–e78
  17. Crum NF, Lee RU, Thornton SA, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus.. Am J Med. 2006;119:943–951
  18. Miller LG, Diep BA. Colonization, fomites, and virulence: rethinking the pathogenesis of community-acquired methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:752–760
  19. Gorwitz RJ, Jemigan DB, Powers JH. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention (March 2006). http://www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA_ExpMtgStrategies.pdfAccessed May 20, 2008
  20. Leonard FC, Markey BK. Meticillin-resistant Staphylococcus aureus in animals: a review. Vet J. 2008;175:27–36
  21. Loeb M, Main C, Walker-Dilks C, et al. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev. 2003;4:CD003340
  22. Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis. 2007;45:541–547
  23. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871–1877
  24. Mody L, Kauffman CA, McNeil SA, et al. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37:1467–1474
  25. Tacconelli E, Carmeli Y, Aizer A, et al. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37:1629–1638
  26. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind randomized, placebo-controlled study. Clin Infect Dis. 2002;35:353–358
  27. Wertheim H, Vos MC, Ott A. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med. 2004;140:419–425
  28. Sandri AM, Dalarosa MG, de Alcaantara LR, et al. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol. 2006;27:185–187
  29. Bradley SF. Eradication or decolonization of methicillin-resistant Staphylococcus aureus: what are we doing and why are we doing it?. Clin Infect Dis. 2007;44:186–189
  30. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis. 2007;44:178–185
  31. Shinefield H, Black S, Fattom A, et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med. 2002;346:491–496

 Disclaimer: The opinions and assertions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the Department of Defense, the Department of the Navy, or the naval services at large.

PII: S0011-5029(08)00123-5

doi: 10.1016/j.disamonth.2008.09.009

Disease-A-Month
Volume 54, Issue 12 , Pages 801-806 , December 2008

Article Tools